Skip to main content

AHI 500 Pill - purple capsule/oblong

Pill with imprint AHI 500 is Purple, Capsule/Oblong and has been identified as Mycophenolate Mofetil 500 mg. It is supplied by Accord Healthcare.

Mycophenolate mofetil is used in the treatment of Nephrotic Syndrome; Organ Transplant, Rejection Prophylaxis; Graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AHI 500

Mycophenolate mofetil 500 mg AHI 500
Mycophenolate mofetil 500 mg AHI 500
Mycophenolate mofetil 500 mg AHI 500 Front
Mycophenolate mofetil 500 mg AHI 500 Back
Mycophenolate mofetil 500 mg AHI 500

Mycophenolate Mofetil

AHI 500
500 mg
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Accord Healthcare
National Drug Code (NDC)
Inactive Ingredients
croscarmellose sodium, magnesium stearate, povidone k90, microcrystalline cellulose, hydroxypropyl cellulose, magnesium silicate, FD&C Blue No. 2, ferrosoferric oxide, ferric oxide red, polyethylene glycol 400, titanium dioxide, hypromellose 2910 (6 mPa.s)

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.